The 61 rating InvestorsObserver gives to Citius Pharmaceuticals Inc (CTXR) stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 71 percent of stocks in the Biotechnology industry, CTXR’s 61 overall rating means the stock scores better than 61 percent of all stocks.
CTXR has an Overall Score of 61. Find out what this means to you and get the rest of the rankings on CTXR!
Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.
What's Happening With Citius Pharmaceuticals Inc Stock Today?
Citius Pharmaceuticals Inc (CTXR) stock is down -3.99% while the S&P 500 has gained 0.68% as of 10:08 AM on Monday, Jan 23. CTXR is down -$0.05 from the previous closing price of $1.38 on volume of 756,453 shares. Over the past year the S&P 500 is down -9.31% while CTXR is down -7.64%. CTXR lost -$0.23 per share the over the last 12 months.
Click Here to get the full Stock Report for Citius Pharmaceuticals Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
